Evaluation of environmental risk factors for prostate cancer in a population of Iranian patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 24, 2014, Pages 10603-10605

  Pouresmaeili, Farkhondeh ^a   Hosseini, S Jalil ^a   Farzaneh, Farah ^b   Karimpour, Arezoo ^a   Azargashb, Eznollah ^b   Yaghoobi, Mohammad ^b   Kamarehei, Maryam ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; AGED; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; EVALUATION STUDY; FOLLOW UP; HUMAN; INCIDENCE; IRAN; MALE; MIDDLE AGED; OCCUPATION; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTOR; SMOKING;

AGED; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCUPATIONS; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 84923007306     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.24.10603     Document Type: Article

References (28)

1. Akbari ME, Hosseini SJ, Rezaee A, et al (2008). Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev, 9, 549-52.
2. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, et al (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran Population-Based Cancer Registry, 1998-2001. Arch Iran Med, 12, 15-23.
3. Askari F1, Parizi MK, Jessri M, et al (2014). Dietary patterns in relation to prostate cancer in Iranian men: a case-control study. Asian Pac J Cancer Prev, 15, 2159-63.
4. Bae JM, Li ZM, Shin MH, Kim DH, et al (2013). Cigarette smoking and prostate cancer risk: negative results of the Seoul Male Cancer Cohort Study. Asian Pac J Cancer Prev, 14, 4667-9.
5. Boffetta P, Nyberg F (2003). Contribution of environmental factors to cancer risk. Br Med Bull, 68, 71-94.
6. Calderon-Garciduenas L, Mora-Tiscareno A, Francolira M, et al (2013). Exposure to urban air pollution and bone health in clinically healthy six-year-old children. Arh Hig Rada Toksikol, 64, 23-34.
7. Center MM, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92.
8. Cerhan JR, Parker AS, Putnam SD, et al (1999). Family history and prostate cancer risk in a population-based cohort of Iowa men family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev, 8, 53-60.
9. Crawford ED (2003). Epidemiology of prostate cancer. Urology, 62, 3-12.
10. Doolan G, Benke G, Giles G (2014). An update on occupation and prostate cancer. Asian Pac J Cancer Prev, 15, 501-16.
11. English KM, Pugh PJ, Parry H, et al (2001). Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clinical Science (Lond), 100, 661-5.
12. Heidenreich A, Bastian PJ, Bellmunt J, et al (2014). EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol, 65, 467-79.
13. Hosseini M, SeyedAlinaghi S, Mahmoudi M, et al (2010). A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran, 48, 61-6.
14. Huncharek M, Haddock KS, Reid R, et al (2010). Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health, 100, 693-701.
15. Joseph MA, Wei JT, Harlow SD, et al (2004). Relationship of serum sex-steroid hormones and prostatevolume in African American Men. Prostate, 329, 322-9.
16. Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev, 13, 4097-100.
17. Mazdak H, Mazdak M, Jamali L, et al (2012). Determination of prostate cancer risk factors in Isfahan, Iran: a case-control study. Med Arh, 66, 45-8.
18. Moslemi MK, Lotfi F, Tahvildar SA (2011). Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience. Cancer Manag Res, 3, 227-31.
19. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
20. Ozbek E, Otunctemur A, Dursun M, et al (2014). The metabolic syndrome is associated with more aggressive prostate cancer. Asian Pac J Cancer Prev, 15, 4029-32.
21. Pour PM (1981). A new prostatic cancer model: systemic induction of prostatic cancer in rats by a nitrosamine. Cancer Lett, 13, 303-8.
22. Pourmand G, Salem S, Mehrsai A, et al (2007). The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev, 8, 422-8.
23. Quinn M, Babb P (2002). Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int, 90, 162-73.
24. Rohani-Rasaf M1, Abdollahi M, Jazayeri S et al (2013). Correlation of cancer incidence with diet, smoking and socio-economic position across 22 districts of Tehran in 2008. Asian Pac J Cancer Prev, 14, 1669-76.
25. Pack R.S., (1993). Epidemiology of prostate cancer; with emphasis on familial clusters. Cancer Bull, 45, 384-9.
26. Winkelstein W, Kantor S (1963). Particulate air pollution, thus replicating findings in the Nashville economic status. Nonlinearity Biol Toxicol Med, 59, 259-92.
27. Yang B, Chen WH, Wen XF, et al (2013). Role of DNA repair-related gene polymorphisms in susceptibility to risk of prostate cancer. Asian Pac J Cancer Prev, 14, 5839-42.
28. Zhou XF, Ding ZS, Liu NB (2013). Allium vegetables and risk of prostate cancer: evidence from 132, 192 subjects. Asian Pac J Cancer Prev, 14, 4131-4.